LONDON, August 27, 2013 /PRNewswire/ --
The U.S. equity market slipped on Monday, August 26, 2013. All three benchmark indexes closed lower, with the Dow Jones Industrial Average falling by 0.43%, the S&P 500 falling by 0.40%, and the NASDAQ Composite declining by 0.01%. Shares in the healthcare sector ended mostly higher even as the broader market declined. The major movers in the sector included Alkermes PLC (NASDAQ: ALKS), Hospira Inc. (NYSE: HSP), Celsion Corporation (NASDAQ: CLSN), and Theravance Inc. (NASDAQ: THRX). All these companies are tracked by AAAResearchReports.com. Free in-depth technical analysis on ALKS, HSP, CLSN, and THRX are currently available upon sign up at:
Alkermes PLC's stock ended 0.46% higher on Monday, reversing some of its recent losses. The company's shares oscillated between $32.61 and $33.27 before finishing the day at $32.86. A total of 0.82 million shares were traded, which is below the daily average volume of 1.41 million. The company's shares have gained 0.09% in the last three trading sessions, underperforming the S&P 500 which has gained 0.85% during the same period. Further, the company's shares are trading above their 50-day and 200-day moving averages. Sign up for free technical analysis on ALKS at:
Hospira Inc.'s stock ended almost flat on Monday, closing the day at $40.29, 0.02% lower than the previous closing price of $40.30. The company's shares oscillated between $40.07 and $40.55. A total of 0.50 million shares were traded, which is below the daily average volume of 0.91 million. The company's shares have gained 2.03% in the last three trading sessions and 14.85% in the last three months, outperforming the S&P 500 which has gained 0.85% and 0.44% during the respective periods. Additionally, Hospira Inc.'s stock is trading above its 50-day and 200-day moving averages. Download free report on HSP by registering at:
Celsion Corporation's stock gained 1.71% on Monday, even as the broader market declined. The company's shares ended the day at $1.19 after fluctuating between $1.16 and $1.19. A total of 0.84 million shares were traded, which is below the daily average volume of 5.00 million. The company's shares have advanced 5.31% in the last three trading sessions and 14.42% in the last three months, outperforming the S&P 500 which has gained 0.85% and 0.44% during the respective periods. Despite Monday's advances, the company's stock continues to trade below its 50-day and 200-day moving averages. The free report on CLSN can be downloaded by signing up now at:
Theravance Inc.'s shares surged on Monday, finishing the day 5.20% higher than the previous day's closing price of $36.12. The company's shares oscillated between $36.18 and $38.26 before ending the session at $38.00. A total of 0.81 million shares were traded, which is below the daily average volume of 1.09 million. The company's stock has gained 4.94% in the last three trading sessions, compared to a gain of 0.85% in the S&P 500 during the same period. Moreover, Theravance Inc.'s stock is currently trading above its 50-day and 200-day moving averages. A free report on THRX can be accessed by registering at:
- This is not company news. We are an independent source and our views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a best efforts basis and reviewed by a CFA ® charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
- This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
- If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com.
- For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com.
- Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider has, through Chartered Financial Analysts, only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
SOURCE AAA Research Reports